iRadimed (NASDAQ:IRMD) versus Advanced Biomedical Technologies (OTCMKTS:ABMT) Financial Contrast

Advanced Biomedical Technologies (OTCMKTS:ABMT) and iRadimed (NASDAQ:IRMD) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, earnings, institutional ownership, analyst recommendations, risk and dividends.

Profitability

This table compares Advanced Biomedical Technologies and iRadimed’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Advanced Biomedical Technologies	N/A	N/A	N/A
iRadimed	27.36%	24.48%	21.25%

Volatility and Risk

Advanced Biomedical Technologies has a beta of 1.46, indicating that its stock price is 46% more volatile than the S&P 500. Comparatively, iRadimed has a beta of 0.91, indicating that its stock price is 9% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Advanced Biomedical Technologies and iRadimed, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Advanced Biomedical Technologies	0	0	0	0	0.00
iRadimed	0	1	3	1	3.00

iRadimed has a consensus target price of $120.00, indicating a potential upside of 22.33%. Given iRadimed’s stronger consensus rating and higher probable upside, analysts plainly believe iRadimed is more favorable than Advanced Biomedical Technologies.

Insider & Institutional Ownership

92.3% of iRadimed shares are held by institutional investors. 34.1% of Advanced Biomedical Technologies shares are held by company insiders. Comparatively, 34.6% of iRadimed shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Valuation & Earnings

This table compares Advanced Biomedical Technologies and iRadimed”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Advanced Biomedical Technologies	N/A	N/A	N/A	N/A	N/A
iRadimed	$83.81 million	14.96	$22.48 million	$1.83	53.60

iRadimed has higher revenue and earnings than Advanced Biomedical Technologies.

Summary

iRadimed beats Advanced Biomedical Technologies on 10 of the 11 factors compared between the two stocks.

About Advanced Biomedical Technologies

Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures. The company was formerly known as Geostar Mineral Corporation and changed its name to Advanced Biomedical Technologies, Inc. in March 2009. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York.

About iRadimed

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.